Inulin Ameliorates Alcoholic Liver Disease via Suppressing LPS-TLR4-M Axis and Modulating Gut Microbiota in Mice

被引:75
|
作者
Yang, Xiaoli [1 ,2 ]
He, Fang [2 ]
Zhang, Yanting [2 ]
Xue, Jing [3 ]
Li, Ke [1 ]
Zhang, Xiaoxia [4 ]
Zhu, Lili [3 ]
Wang, Zhen [1 ]
Wang, Hao [3 ]
Yang, Shaoqi [2 ]
机构
[1] Ningxia Med Univ, Clin Med Coll, Ningxia, Peoples R China
[2] Ningxia Med Univ, Gen Hosp, Dept Gastroenterol, Ningxia 750004, Peoples R China
[3] Ningxia Med Univ, Dept Pathogen Biol & Med Immunol, Sch Basic Med Sci, Ningxia 750004, Peoples R China
[4] Ningxia Med Univ, Coll Tradit Chinese Med, Ningxia, Peoples R China
关键词
Inulin; Alcoholic Liver Disease; LPS-TLR4-M Axis; Gut Microbiota; SUPPLEMENTATION; COMMUNITIES; BURDEN; INFLAMMATION; ENDOTOXEMIA; CONTRIBUTES; INJURY; LEVEL; CELLS; ACID;
D O I
10.1111/acer.13950
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
BackgroundAlcoholic liver disease (ALD) represents a chronic liver disorder caused by alcohol abuse. Numerous studies have demonstrated that gut microbiota dysbiosis plays a critical role in ALD pathogenesis. Application of prebiotic, probiotic, and dietary supplementation to the modulation of gut microbiota contributes to a novel approach to the management of ALD. Inulin, a natural prebiotic found in plants, can restore gut dysbiosis in ALD. However, the exact mechanism of dietary inulin in ALD remains largely unknown. MethodsSixty female C57BL/6J mice were randomly divided into 4 groups: pair-fed (PF) group (PF/CON); alcohol-fed (AF) group (AF/CON); PF with inulin (INU) group (PF/INU); and AF with INU group (AF/INU). All mice were fed with isocaloric modified Lieber-DeCarli liquid diets with or without alcohol. ResultsAfter 6weeks of feeding, mice were euthanized and associated indications were investigated. The results showed that chronic ethanol (EtOH) intake led to the loss of body weights, abnormal levels of transaminases, and inflammatory indicators (lipopolysaccharide [LPS], interleukin [IL]-6, IL-10, tumor necrosis factor-, IL-17A), while inulin administration ameliorated these effects. To further understand the underlying mechanism, we investigated macrophages (Ms) and gut microbiota in diverse groups. The number of Ms was reduced after dietary inulin treatment in chronic EtOH exposure. Hepatic Toll-like receptor 4 (TLR4(+)) Ms in AF/INU group were lower than AF/CON group. 16S rRNA sequencing and analysis of gut microbiota indicated the reduction of Allobaculum, Lactobacillus, and Lactococcus, as well as the increase of Parasutterella in AF group compared with PF control. Increased Allobaculum, Lactobacillus, and Lactococcus but reduced Parasutterella in AF/INU group were confirmed that dietary inulin rectified gut dysbiosis to attenuate ALD. ConclusionsDietary inulin ameliorates ALD via suppressing LPS-TLR4-M axis and modulating gut microbiota in mice, thus potentially provides theoretical foundation for inulin intervention in the prevention and treatment of ALD.
引用
收藏
页码:411 / 424
页数:14
相关论文
共 50 条
  • [41] Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice
    Xue, Jing
    Li, Xiaorong
    Liu, Ping
    Li, Ke
    Sha, Liping
    Yang, Xiaoli
    Zhu, Lili
    Wang, Zhen
    Dong, Youping
    Zhang, Li
    Lei, Hong
    Zhang, Xiaoxia
    Dong, Xiaoying
    Wang, Hao
    ENDOCRINE JOURNAL, 2019, 66 (10) : 859 - 870
  • [42] Jian Gan powder ameliorates immunological liver injury in mice by modulating the gut microbiota and metabolic profiles
    Li, Kun
    Cui, Yadong
    Zheng, Xue
    Min, Chunyan
    Zhang, Jian
    Yan, Zhanpeng
    Ji, Yu
    Ge, Fei
    Ji, Hualiang
    Zhu, Fangshi
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2024, 29 (01)
  • [43] Fecal microbiota transplantation protects rotenone-induced Parkinson’s disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
    Zhe Zhao
    Jingwen Ning
    Xiu-qi Bao
    Meiyu Shang
    Jingwei Ma
    Gen Li
    Dan Zhang
    Microbiome, 9
  • [44] Fecal microbiota transplantation protects rotenone-induced Parkinson's disease mice via suppressing inflammation mediated by the lipopolysaccharide-TLR4 signaling pathway through the microbiota-gut-brain axis
    Zhao, Zhe
    Ning, Jingwen
    Bao, Xiu-Qi
    Shang, Meiyu
    Ma, Jingwei
    Li, Gen
    Zhang, Dan
    MICROBIOME, 2021, 9 (01)
  • [45] Trilobatin, a Novel Naturally Occurring Food Additive, Ameliorates Alcoholic Liver Disease in Mice: Involvement of Microbiota-Gut-Liver Axis and Yap/Nrf2 Signaling Pathway
    Yi, Yang
    Yan, You
    Zhan, Guiyu
    Deng, Weikun
    Wei, Yu
    Zhang, Yuandong
    Gao, Jianmei
    Gong, Qihai
    JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY, 2024, 72 (43) : 23819 - 23831
  • [46] OLIGOFRUCTOSE AMELIORATES NONALCOHOLIC FATTY LIVER DISEASE BY REGULATING GUT MICROBIOTA DYSBIOSIS IN MICE
    Huang, Xiaoqing
    Yan, Changsheng
    Wu, Jingtong
    Zhang, Xiang
    Ren, Jianlin
    GUT, 2019, 68 : A54 - A54
  • [47] Xiaoyaosan against depression through suppressing LPS mediated TLR4/ NLRP3 signaling pathway in "microbiota-gut-brain" axis
    Liu, Xiaojie
    Liu, Huimin
    Wu, Xiaoling
    Zhao, Ziyu
    Wang, Senyan
    Wang, Huimin
    Qin, Xuemei
    JOURNAL OF ETHNOPHARMACOLOGY, 2024, 335
  • [48] Fucoidan from Apostichopus japonicus ameliorates alcoholic liver disease by regulating gut-liver axis homeostasis
    Li, Yuan
    Huan, Yuchen
    Qin, Wanting
    Yu, Xinyue
    Chang, Yaoguang
    Xue, Changhu
    Tang, Qingjuan
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 270
  • [49] Fecal microbiota transplantation mitigates postdieting weight regain in mice by modulating the gut-liver axis
    Cao, Hong
    Xu, Jiangwei
    Wang, Han
    Yi, Wanya
    Yang, Dandan
    Yang, Ju
    Sun, Jing
    Wang, Yingyu
    Zhang, Feng
    Yan, Jiai
    Li, Dan
    BMC MICROBIOLOGY, 2025, 25 (01):
  • [50] Caulerpa lentillifera Ameliorates Inflammation in Mice via Modulating TLR4 Signaling Pathway
    Lin, Kuan-Yu
    Chen, Jiun-Rong
    Yang, Hsin-Yi
    ANNALS OF NUTRITION AND METABOLISM, 2019, 75 : 255 - 255